Dynocardia

Lowell, MA · Founded 2015 · Privately Held (backing)

Developer of a wearable blood pressure monitoring device designed to accurately and continuously measure blood pressure. Dynocardia is based in Lowell, MA and was founded in 2015. Its last reported valuation was $12.5 million in Jan 2021. It has raised $8.3 million across 4 recorded rounds; the latest was a $1.2 million seed round in Mar 2025.

Last reported valuation
$12.5M
Oct 2026
Priced at
—
Total raised
$8.3M
Last round
Seed Round
Mar 2025
What is Dynocardia worth?
$12.5Mlast reported valuation · Oct 2026

Dynocardia's last reported valuation, Jan 2021. Nothing priced has surfaced since.

Free account
More of Dynocardia with a free account
  • ·The complete investor list: 11 names
  • ·Watch Dynocardia: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Dynocardia funding history

4 rounds
DateRoundRaisedPost-money
Mar 2025Seed Round$1.2M▮
Mar 2023Seed Round$4.8M▮
Jan 2020Debt$2.0M▮
Apr 2019Debt$490K▮
Unlock post-money valuations

Membership and data by Private Market View

Dynocardia valuation

Dynocardia's last reported valuation was $12.5 million in Jan 2021. No priced round, secondary trade or fund mark has surfaced since.

How much has Dynocardia raised?

Dynocardia has raised $8.3 million across 4 recorded rounds since 2019. The largest was a $489,999 debt round in Apr 2019; the most recent was a $1.2 million seed round in Mar 2025.

Dynocardia has filed 12 Form Ds with the SEC since 2019, most recently in Dec 2025 ($4.8 million sold to 47 investors).

How Dynocardia's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Dynocardia, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →

Frequently asked about Dynocardia

What is Dynocardia worth?
Dynocardia is valued at $12.5M as of Oct 2026. Dynocardia's last reported valuation, Jan 2021. Nothing priced has surfaced since.
How much has Dynocardia raised?
Dynocardia has raised $8.3M in total funding across 4 recorded rounds.
When did Dynocardia last raise?
Dynocardia last raised in Mar 2025 (Seed Round), raising $1.2M.